Acutus Medical Inks Marketing Deal With Biotronik, Mapping Its Way To Electrophysiologists Outside US
Biotronik will help Acutus to bring its cardiac mapping software and guidance system to electrophysiologists worldwide.
You may also be interested in...
The deal, potentially worth more than $85m, will allow Acutus to get more revenue from its core AcQMap electrophysiology mapping technology and invest in the development of its pulsed field ablation system.
The company is supporting two US trials of the AcQBlate Force ablation catheter to support FDA approval of the system to treat atrial flutter and atrial fibrillation.
The IPO is expected to raise $166m to support R&D of new arrhythmia mapping and ablation technologies and expand commercial operations.